SCHEMBL7697941

SCHEMBL7697941

COc1ccc(C(=O)Nc2ccc(/C(O)=C(\O)c3ccc(NC(=O)c4ccc(OC)c(S(=O)(=O)N5CCN(C)CC5)c4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)cc1S(=O)(=O)N1CCN(C)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.58
CASP3 P42574 1/20 0.58
RAB9A P51151 1/20 0.58
SENP8 Q96LD8 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58
MAPK1 P28482 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
ALDH1A1 P00352 3/20 0.57
KDM4E B2RXH2 1/20 0.57
GAA P10253 1/20 0.57
LMNA P02545 5/20 0.54
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
HSD17B10 Q99714 2/20 0.54
TSHR P16473 1/20 0.54
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
POLB P06746 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8023083 0.93 RAB9A (0.56) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL7698195 0.91 NPC1 (0.57) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL7664974 0.87 RAB9A (0.56) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL7665077 0.87 RAB9A (0.56) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL8019190 0.85 RAB9A (0.66) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL8008535 0.84 RAB9A (0.65) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL8019362 0.83 ALDH1A1 (0.59) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL7691765 0.81 MAPK1 (0.59) MAPK1SMN1; SMN2ALDH1A1KDM4EGAA
SCHEMBL7661277 0.80 RAB9A (0.67) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL7657503 0.79 RAB9A (0.66) NPC1CASP3RAB9ASENP8SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists AMERICAN HOME PRODUCTS CORPORATION (US) 2002-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111369-A1 Aryl sulfonic acids and derivatives as FSH antagonists FSHR, GNRHR, LHCGR NPC1 367/4885CASP3 3958/4885RAB9A 2770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.